Alpha-1 antitrypsin deficiency is an inherited condition that can affect the lungs and liver. Its name describes a shortage of a protective protein, often shortened to AAT. But the amount of protein is only part of the story: some genetic changes also cause abnormal protein to collect inside liver cells. Understanding these different effects helps explain why testing and care consider both organs. MedlinePlus Genetics explains the condition.
How the lungs and liver are involved
The liver makes AAT and releases it into the bloodstream. In the lungs, AAT helps control an enzyme called neutrophil elastase. This enzyme participates in the body’s response to infection, but uncontrolled activity can damage healthy lung tissue. Too little working AAT leaves the small air sacs vulnerable to damage, potentially causing emphysema. Certain abnormal forms of AAT can also accumulate in the liver and injure it. These are different mechanisms affecting different organs. See the genetic and protein mechanisms.
What the genetic letters mean
The SERPINA1 gene contains instructions for making AAT. People usually inherit one copy from each parent. Reports may use letters to describe common versions, called alleles. M generally produces normal amounts of AAT, while S and Z are associated with reduced amounts. The combination matters: ZZ is associated with substantially greater lung and liver risks than many other combinations. MedlinePlus describes these allele combinations.
This inheritance pattern is called autosomal codominant: both inherited versions contribute to the protein characteristics. Someone with an MZ result may be described as a carrier, yet that label does not mean there is no health relevance. MZ is associated with increased lung risk, particularly with smoking. A genetic combination helps assess susceptibility; it cannot tell exactly whether or when disease will develop. NHGRI explains inheritance and carrier implications.
Three tests answer different questions
AAT testing is used when lung or liver findings suggest the condition, and sometimes when a relative has an established diagnosis. It can involve several complementary measurements:
- Blood AAT level: how much protein is circulating?
- Protein typing: what form of AAT is present?
- Genotyping: which tested SERPINA1 changes are present?
A low blood level usually needs further protein or genetic testing to establish its explanation. Conversely, a genetic report does not measure current lung or liver function. Those require separate assessment. Common-variant genotyping looks for selected changes, so understanding what the laboratory tested matters when interpreting a result. MedlinePlus explains AAT testing and follow-up.
Why outcomes remain uncertain
Symptoms and their timing vary. Lung problems may include breathlessness, wheezing or reduced exercise tolerance. Liver disease can occur in childhood or adulthood. These findings also have other possible causes, so symptoms alone cannot establish AAT deficiency. NHGRI describes the clinical features and diagnostic assessment.
Smoking and other inhaled exposures can influence lung damage. This means inherited susceptibility and environmental exposure both matter. Even after a genetic diagnosis, assessment of actual organ function remains essential; the genotype is not a timetable for future illness. See the role of exposure and organ assessment.
Established care and research claims
Established management focuses on preventing or slowing damage and treating the problems present. Avoiding tobacco smoke is a central part of lung protection. Treatment is guided by clinical findings; selected patients may receive replacement AAT, called augmentation therapy. Its availability does not mean everyone with a SERPINA1 variant needs it. NHGRI outlines management approaches.
When evaluating research, the useful questions are what was measured and whether it demonstrates patient benefit. A change in protein level, lung function and liver health are different outcomes. Claims about a new treatment need evidence for the relevant outcome, its durability and safety before they can guide routine care.
What a result can mean for relatives
A confirmed diagnosis can raise testing questions for family members, including people without symptoms. Genetic counselling can explain inheritance, the benefits and limits of testing, and reproductive implications. Family testing can clarify an inherited result, while each person’s health assessment remains a separate task. MedlinePlus describes family testing and counselling.